IP Library Granted Patent US 9,707,335
Granted Patent B2
US 9,707,335 · App. 14/230,784 · Granted Jul 18, 2017

Drive mechanism for drug delivery pumps with integrated status indication

Inventors: Ryan M. Agard (Royersford, PA); Ian B. Hanson (Wayne, PA); Nicholas J. Ciccarelli (Philadelphia, PA); Sean M. O'Connor (West Chester, PA); Kevin Bokelman (San Diego, CA); Paul F. Bente, IV (Wayne, PA); John C. Love (San Diego, CA); Christopher Edward Hatch (San Diego, CA)
Assignee: Unitract Syringe PTY LTD
A61M5/14216A61M5/14248A61M5/14566A61M2005/14252A61M2005/2474A61M2205/58A61M2205/82
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,707,335
App. No.
14/230,784
Granted
Jul 18, 2017
Kind
B2
Abstract

A drive mechanism includes a housing, a piston adapted to impart movement to a plunger seal within a drug container, a plurality of biasing members disposed in parallel, and a retainer. The biasing members are disposed to release energy to cause movement of the piston from a retracted first position to the extended second position, the piston bearing against the plunger seal to dispense medicine. The retainer is disposed to maintain the biasing members in the energized position and to release the biasing members to permit the piston to dispense the medicine. The drive mechanism may also include an end-of-dose indicator to identify at least one of when the sleeve assembly is disposed subjacent a window in the housing, the relative motion of the sleeve assembly with reference to the window or another reference component, the stoppage of such motion, and the rated or change of rate of motion.

Claims (26)

1. A drug pump drive mechanism for use in cooperation with a drug container including a plunger seal and a power and control system, the drive mechanism comprising:

a drive housing including an axis, the housing further including at least one window,

a piston disposed for movement from at least a retracted first position to an extended second position along said axis, the piston adapted to impart movement to the plunger seal within the drug container,

at least one biasing member disposed and adapted to move from an energized first position to a deenergized second position as a result of the release of energy, the biasing member being disposed to cause movement of the piston from the retracted first position to the extended second position as the biasing member moves from the energized first position to the deenergized second position,

a retainer, the retainer being moveable between a retaining first position and a releasing second position, the retainer disposed to maintain the biasing member in the energized first position when the retainer is in the retaining first position, and to release the biasing member from the first energized position when the retainer moves to the releasing second position,

a sleeve assembly disposed at least partially within the drive housing, at least a portion of the sleeve assembly being adapted to move along said axis with the piston, at least a portion of the sleeve assembly being visible through said window when the piston is one of the retracted first position or the extended second position, the sleeve assembly not being visible through said window when the piston is in the other of the retracted first position or the extended second position, and

an end-of-dose indicator, the end-of-dose indicator including at least one switch interconnect, at least a portion of which is disposed substantially adjacent the window and adapted to identify at least one of when the sleeve assembly is disposed subjacent the window and when the sleeve assembly is not disposed subjacent the window, the switch interconnect including a mechanical trigger adapted to engage the sleeve assembly through the window, the switch interconnect further being adapted to selectively engage the power and control system as a result of the engagement or disengagement end of the trigger.

2. The drug pump drive mechanism as claimed in claim 1 wherein the sleeve assembly is not visible through the window when the piston is in the extended position, and the trigger engages the sleeve assembly when the piston is in the retracted position.

3. The drug pump drive mechanism as claimed in claim 2 wherein the switch interconnect engages the power and control system when the trigger engages the sleeve assembly.

4. The drug pump drive mechanism as claimed in claim 1 wherein the switch interconnect engages the power and control system when the trigger engages the sleeve assembly.

5. The drug pump drive mechanism as claimed in claim 1 wherein the switch interconnect is disposed to selectively engage a PCB board of the power and control system dependent upon the position of the trigger relative to the sleeve assembly.

6. The drug pump drive mechanism as claimed in claim 1 including at least two switch interconnects disposed at least partially substantially adjacent the window.

7. The drug pump drive mechanism as claimed in claim 6 wherein at least one of the switch interconnects includes a mechanical trigger adapted to engage the sleeve assembly through the window, and the switch interconnect engages the power and control system when the associated trigger engages the sleeve assembly.

8. The drug pump drive mechanism as claimed in claim 6 wherein at least one of the switch interconnects includes a mechanical trigger adapted to engage the sleeve assembly through the window, and the switch interconnect does not engage the power and control system when the associated trigger engages the sleeve assembly.

9. The drug pump drive mechanism as claimed in claim 6 further including the sleeve assembly disposed about the at least one biasing member, the switch interconnects including respective mechanical triggers adapted to engage the sleeve assembly through the window, the triggers being disposed such that at least one of the triggers does not engage the biasing member through the associated when the sleeve assembly is not disposed subjacent the window.

10. The drug pump drive mechanism as claimed in claim 9 including at least two windows and at least two switch interconnects disposed substantially adjacent the windows, respectively.

11. The drug pump drive mechanism as claimed in claim 1 including at least two windows and at least two switch interconnects disposed substantially adjacent the windows, respectively.

12. The drug pump drive mechanism as claimed in claim 1 wherein the sleeve assembly has a trailing edge, and the mechanical trigger sensor is disposed in a first position bearing against the sleeve assembly when the piston is in the retracted first position and a second position when the trailing edge of the sleeve assembly moves axially past the window.

13. The drug pump drive mechanism as claimed in claim 1 wherein the sleeve assembly includes a plurality of telescoping sleeves.

14. The drug pump drive mechanism as claimed in claim 6 wherein the sleeve assembly includes a plurality of telescoping sleeves.

15. The drug pump drive mechanism as claimed in claim 1 including at least two biasing members, the sleeve assembly being disposed about the at least two biasing members.

16. The drug pump drive mechanism as claimed in claim 6 including at least two biasing members, the sleeve assembly being disposed about the at least two biasing members.

17. The drug pump drive mechanism as claimed in claim 1 wherein the at least one biasing member includes a pair of compression springs.

18. The drug pump drive mechanism as claimed in claim 17 wherein the compression springs are concentrically disposed.

19. The drug pump drive mechanism as claimed in claim 6 wherein the at least one biasing member includes a pair of compression springs.

20. The drug pump drive mechanism as claimed in claim 19 wherein the compression springs are concentrically disposed.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2025
From: UNL HOLDINGS LLC
To: AMGEN INC.
Reel/Frame 073057/0641 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2017
From: UNILIFE CORPORATION; UNILIFE MEDICAL SOLUTIONS, INC.; UNITRACT SYRINGE PTY LTD ACN 101 059 723; UNILIFE MEDICAL SOLUTIONS PTY LIMITED ACN 008 071 403
To: UNL HOLDINGS LLC
Reel/Frame 043482/0722 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 1, 2017
From: AGARD, RYAN M.; HANSON, IAN B.; CICCARELLI, NICHOLAS J.; O'CONNOR, SEAN M.; BOKELMAN, KEVIN; BENTE, PAUL F., IV; LOVE, JOHN C.; HATCH, CHRISTOPHER EDWARD
To: UNITRACT SYRINGE PTY LTD
Reel/Frame 042563/0382 →
Continuity (7)
Continuation In Part PCTUS2014013005 · Jan 24, 2014
Continuation In Part 14163690 · Jan 24, 2014
Continuation In Part 13600114 · Aug 30, 2012
Provisional Application 61756667 · Jan 25, 2013
Provisional Application 61912642 · Dec 6, 2013
Provisional Application 61530788 · Sep 2, 2011
Related Publication 20140296787A1 · Oct 2, 2014